Clinical Trial Update: Study to Assess the Safety and Change in Disease Symptoms of Risankizumab (Skyrizi) in Adult Participants With Moderate to Severe Plaque Psoriasis and Psoriatic Arthritis

View source ↗

Summary

This clinical trial update reports safety findings and changes in disease symptoms for risankizumab (Skyrizi) in adults with moderate-to-severe psoriasis and ps…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Psoriasis
• Psoriatic Arthritis

Drugs mentioned

• SKYRIZI (risankizumab-rzaa)

Snippet

Sponsor: AbbVie | Conditions: Psoriasis, Psoriatic Arthritis | Status: COMPLETED